Company profile
MIRA PHARMACEUTICALS, INC.
NASDAQ:MIRABiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07791303 | phase1 | completed | 2025-03-20 | 2026-03-05 | MIRA Pharmaceuticals | Safety, Tolerability and Pharmacokinetics of Oral Ketamir-2 in Healthy Adult Subjects |
FDA applications (0)
No records yet.